CraigFredLaForceMD

PubMed

• A randomized, controlled trial to investigate the effect of ciclesonide and beclomethasone dipropionate on eye lens opacity.
  Chylack LT, Gross GN, Pedinoff A, Ciclesonide Lenticular Safety Study Group> ;The Journal of asthma : official journal of the Association for the Care of Asthma.
• Evaluation of olopatadine hydrochloride nasal spray, 0.6%, used in combination with an intranasal corticosteroid in seasonal allergic rhinitis.
  LaForce CF, Carr W, Tilles SA, Chipps BE, Storms W, Meltzer EO, Edwards M> ;Allergy & rhinology (Providence, R.I.).
• Step-Up Therapy in Black Children and Adults with Poorly Controlled Asthma.
  Wechsler ME, Szefler SJ, Ortega VE, Pongracic JA, Chinchilli V, Lima JJ, Krishnan JA, Kunselman SJ, Mauger D, Bleecker ER, Bacharier LB, Beigelman A, Benson M, Blake K...> ;The New England journal of medicine.
• 8 citations
  Pharmacogenetic studies of long-acting beta agonist and inhaled corticosteroid responsiveness in randomised controlled trials of individuals of African descent with as...
  Victor E. Ortega, Michelle Daya, Stanley J. Szefler, Eugene R. Bleecker, Vernon M. Chinchilli, Wanda Phipatanakul, Dave Mauger, Fernando D. Martinez, Esther Herrera-Lu...> ;The Lancet. Child & Adolescent Health. 2021 Nov 9
• 6 citations
  Albuterol/budesonide for the treatment of exercise-induced bronchoconstriction in patients with asthma: the TYREE study
  Craig LaForce, Bradley E. Chipps, Frank C. Albers, Laurence Reilly, Eva Johnsson, Helen Andrews, Christy Cappelletti, Andrea Maes, Alberto Papi> ;Annals of Allergy, Asthma & Immunology. 2021 Oct 24
• 3 citations
  Dose-Ranging and Cumulative Dose Studies of Albuterol Sulfate MDI in Co-Suspension Delivery™ Technology (AS MDI; PT007) in Patients with Asthma: the ASPEN and ANTORA T...
  Christy Cappelletti, Andrea Maes, Kimberly Rossman, Michael Gillen, Craig LaForce, Edward Kerwin, Colin Reisner> ;Clinical Drug Investigation. 2021 Jun 4
• Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial.
  Han JK, Bachert C, Fokkens W, Desrosiers M, Wagenmann M, Lee SE, Smith SG, Martin N, Mayer B, Yancey SW, Sousa AR, Chan R, Hopkins C, SYNAPSE study investigators> ;The Lancet. Respiratory medicine. 2021-04-16
• 76 citations
  Mometasone or Tiotropium in Mild Asthma with a Low Sputum Eosinophil Level
  Stephen C. Lazarus, Jerry A. Krishnan, Tonya S. King, Jason E. Lang, Kathryn V. Blake, Ronina A. Covar, Njira L Lugogo, Sally E. Wenzel, Vernon M. Chinchilli, David T....> ;The New England Journal of Medicine. 2019 May 19
• 5 citations
  Long-term safety of tiotropium/olodaterol Respimat® in patients with moderate-to-very severe COPD and renal impairment in the TONADO® studies.
  Craig Laforce, Eric Derom, Ulrich Bothner, Isabel Kloer, Matthias Trampisch, Roland Buhl> ;International Journal of Chronic Obstructive Pulmonary Disease. 2018 Jun 1
• 79 citations
  Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial.
  Gary T Ferguson, J. Mark FitzGerald, Eugene R. Bleecker, Michel Laviolette, David I. Bernstein, Craig LaForce, Lyndon Mansfield, Peter Barker, Yanping Wu, Maria Jison,...> ;The Lancet. Respiratory Medicine. 2017 Jul 1
• 23 citations
  Randomized, placebo-controlled study of cetirizine and loratadine in children with seasonal allergic rhinitis.
  Anjuli Nayak, William E. Berger, Craig LaForce, Eduardo Urdaneta, Mitesh Patel, Kathleen B. Franklin, Mei-Miau Wu> ;Allergy and Asthma Proceedings. 2017 May 1
• 21 citations
  A randomized study of BI 671800, a CRTH2 antagonist, as add-on therapy in poorly controlled asthma.
  David Miller, Chester C. Wood, Eric D. Bateman, Craig LaForce, Jon Blatchford, James Hilbert, Abhya Gupta, Andrew Fowler> ;Allergy and Asthma Proceedings. 2017 Mar 1
• 5 citations
  Albuterol multidose dry powder inhaler efficacy and safety versus placebo in children with asthma.
  Craig LaForce, Herminia Taveras, Harald Iverson, Paul Shore> ;Allergy and Asthma Proceedings. 2017 Jan 28
• 16 citations
  Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study.
  Craig LaForce, Gregory Feldman, Selwyn Spangenthal, Joerg H Eckert, Michelle Henley, Francesco Patalano, Peter D'Andrea> ;International Journal of Chronic Obstructive Pulmonary Disease. 2016 Jun 8
• 7 citations
  Randomised, double-blind, placebo-controlled crossover study to investigate different dosing regimens of olodaterol delivered via Respimat® in patients with moderate t...
  Kai-Michael Beeh, Craig LaForce, Martina Gahlemann, Arne Wenz, Robert Toorawa, Matjaž Fležar> ;Respiratory Research. 2015 Jul 16
• 25 citations
  Impact of exhaled nitric oxide measurements on treatment decisions in an asthma specialty clinic
  Craig LaForce, Elizabeth Brooks, Nancy Herje, Paul Dorinsky, Kathy Rickard> ;Annals of Allergy, Asthma & Immunology. 2014 Dec 1
• Once-daily indacaterol 75 μg in moderate- to-severe COPD: results of a Phase IV study assessing time until patients' perceived onset of effect.
  Thomas Siler, Craig LaForce, Farid Kianifard, James Williams, Selwyn Spangenthal> ;International Journal of Chronic Obstructive Pulmonary Disease. 2014 Sep 1
• 34 citations
  The 24-h FEV1 time profile of olodaterol once daily via Respimat® and formoterol twice daily via Aerolizer® in patients with GOLD 2-4 COPD: results from two 6-week cro...
  Gregory Feldman, Jonathan A. Bernstein, Alan Hamilton, Michael Chadham Nivens, Lawrence Korducki, Craig LaForce> ;Springerplus. 2014 Aug 9
• 29 citations
  Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/ salmeterol (250/50 mcg) in COPD patients
  Mark T. Dransfield, Gregory Feldman, Phillip Korenblat, C. LaForce, Nicholas Locantore, Massimo Pistolesi, Michael L. Watkins, Courtney Crim, Fernando J. Martinez> ;Respiratory Medicine. 2014 Aug 1
• 12 citations
  Effect of cetirizine on symptom severity and quality of life in perennial allergic rhinitis.
  David P. Skoner, Craig LaForce, Robert A. Nathan, Eduardo Urdaneta, Michael A Zielinski, Steven D Sacavage, Kathleen B. Franklin, Mei-Miau Wu> ;Allergy and Asthma Proceedings. 2014 Jul 1
• 190 citations
  Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial.
  Mario Castro, Tonya S. King, Susan J. Kunselman, Michael D. Cabana, Loren C. Denlinger, Fernando Holguin, Shamsah Kazani, Wendy C. Moore, James N. Moy, Christine A. So...> ;JAMA. 2014 May 28
• Tiotropium Respimat inhaler and the risk of death in COPD.
  Wise RA, Anzueto A, Cotton D, Dahl R, Devins T, Disse B, Dusser D, Joseph E, Kattenbeck S, Koenen-Bergmann M, Pledger G, Calverley P, TIOSPIR Investigators> ;The New England journal of medicine. 2013-08-30
• 20 citations
  Fluticasone/Formoterol combination therapy compared with monotherapy in adolescent and adult patients with mild to moderate asthma.
  David S. Pearlman, Craig LaForce, Kirsten Kaiser> ;Clinical Therapeutics. 2013 Jul 1
• 20 citations
  Ocular safety of fluticasone furoate nasal spray in patients with perennial allergic rhinitis: a 2-year study
  C. LaForce, Glen E. Journeay, S. David Miller, Mary Jane Silvey, W. Wu, Laurie A. Lee, Leo T. Chylack> ;Annals of Allergy, Asthma & Immunology. 2013 Jul 1
• 50 citations
  Randomized, double-blind, placebo-controlled, safety and immunogenicity study of 4 formulations of Anthrax Vaccine Adsorbed plus CPG 7909 (AV7909) in healthy adult vol...
  Robert J. Hopkins, Nancy F. Daczkowski, Paulina E. Kaptur, Derek Muse, Eric Sheldon, Craig LaForce, Suha Sari, Thomas L. Rudge, Edward Bernton> ;Vaccine. 2013 Jun 26
• Join now to see all